Kotomolide A arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells-Reference-Cited by-同舟云学术

Kotomolide A arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells

Published:2008-07 Issue:7 Volume:46 Page:2476-2484
ISSN:0278-6915
Container-title:Food and Chemical Toxicology
language:en
Short-container-title:Food and Chemical Toxicology

Author:

Chen Chung-Yi,Hsu Ya-Ling,Tsai Yu-Chieh,Kuo Po-Lin

Publisher

Elsevier BV

Subject

Toxicology,General Medicine,Food Science

Reference43 articles.

1. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells;Agarwal;Mol. Cancer Ther.,2006

2. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins;Belguendouz;Biochem. Pharmacol.,1997

3. Antiplatelet activity of cis-resveratrol;Bertelli;Drugs Exp. Clin. Res.,1996

4. Bioavailability of all-trans and cis-isomers of lycopene;Boileau;Exp. Biol. Med. (Maywood),2002

5. The mismatch repair system is required for S-phase checkpoint activation;Brown;Nat. Genet.,2003

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Candidate Diagnostic gene CDC25C for Trametinib-induced Cardiotoxicity by Integrating Bioinformatics and Machine Learning;2024-05-08

2. Metabolites from Cinnamomum subavenium with Anti-Dengue Virus Activity;Chemistry of Natural Compounds;2024-01

3. Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development;World Journal of Gastrointestinal Oncology;2023-10-15

4. A New Dimeric Benzenoid of Cinnamomum randaiense;Chemistry of Natural Compounds;2023-05

5. Potential Phytochemicals for Prevention of Familial Breast Cancer with BRCA Mutations;Current Drug Targets;2023-04